gentamicin

gentamicin is an aminoglycoside antibiotic used to treat several types of bacterial infections. It is particularly effective against Gram-negative bacteria such as Pseudomonas aeruginosa and is often reserved for serious infections like meningitis, pneumonia, and sepsis. This medication is typically administered via intravenous injection or intramuscular injection, though topical formulations are also available for skin and eye infections.

Medical uses

Gentamicin is primarily indicated for severe infections caused by susceptible organisms, including complicated urinary tract infections, intra-abdominal infections, and infective endocarditis. It is a critical component in the empirical treatment of hospital-acquired pneumonia and neutropenic fever in patients undergoing chemotherapy. The World Health Organization includes it on its List of Essential Medicines. For ophthalmic use, it is formulated as eye drops or ointment to treat conditions like bacterial conjunctivitis and keratitis. Its use is often guided by antimicrobial susceptibility testing from institutions like the Clinical and Laboratory Standards Institute.

Mechanism of action

As an aminoglycoside, gentamicin exerts its bactericidal effect by binding irreversibly to the 30S ribosomal subunit of bacterial ribosomes. This binding interferes with the initiation complex during protein synthesis, leading to misreading of messenger RNA and incorporation of incorrect amino acids, which produces nonfunctional or toxic peptides. The drug is also known to disrupt bacterial cell membrane integrity, further contributing to cell death. This dual action is particularly effective against aerobic organisms, as its uptake into bacterial cells is an oxygen-dependent process.

Adverse effects

The most significant adverse effects of gentamicin are nephrotoxicity and ototoxicity, which can be irreversible. Ototoxicity may manifest as vestibular dysfunction or cochlear damage, leading to symptoms like vertigo, tinnitus, and sensorineural hearing loss. These risks are heightened with prolonged therapy, high doses, or concurrent use of other nephrotoxic agents like vancomycin or cisplatin. Other potential effects include neuromuscular blockade, which can exacerbate conditions like myasthenia gravis, and rare hypersensitivity reactions. Monitoring through therapeutic drug monitoring of peak and trough levels is standard practice to mitigate toxicity.

Pharmacokinetics

Gentamicin is poorly absorbed from the gastrointestinal tract and is therefore administered parenterally. It distributes widely into extracellular fluid but achieves poor penetration into the cerebrospinal fluid, bile, and prostate gland. The drug is not metabolized and is excreted almost entirely unchanged by glomerular filtration in the kidney. Its elimination half-life is approximately 2-3 hours in patients with normal renal function but can be significantly prolonged in those with renal impairment or conditions like cystic fibrosis. Dosing regimens, including once-daily or extended-interval dosing, are often adjusted based on creatinine clearance calculations.

History

Gentamicin was discovered in 1963 by Marvin J. Weinstein and his colleagues at the Schering Corporation, now part of Merck & Co.. It was isolated from the actinobacterium Micromonospora purpurea, found in a soil sample. Its introduction marked a significant advancement in treating infections caused by Pseudomonas and other resistant Gram-negative bacteria during a period of increasing antibiotic resistance. The development and clinical trials leading to its approval were influenced by earlier work on streptomycin by Selman Waksman at Rutgers University.

Society and culture

Gentamicin is available as a generic medication and is marketed under various trade names worldwide, such as Garamycin. Its cost and accessibility have made it a vital tool in global health, particularly in resource-limited settings. The drug has been the subject of numerous clinical trials and guidelines from bodies like the Infectious Diseases Society of America. Its use is sometimes controversial due to toxicity concerns, leading to legal cases and heightened regulatory scrutiny by agencies including the Food and Drug Administration and the European Medicines Agency.